Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACORDIS: Azathioprine Dose-Ranging in Crohn's Disease
NCT00098111Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azathioprine in Crohn's disease, sponsored by Massachusetts General Hospital. Started Apr 2005; status: terminated.
02
Drugs
azathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00098111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098111.